< 0 1 0 1 O
3 2 3 2 3 B-upper_bound
X 4 5 4 5 I-upper_bound
institutional 6 19 6 19 I-upper_bound
upper 20 25 20 25 I-upper_bound
limit 26 31 26 31 I-upper_bound
of 32 34 32 34 I-upper_bound
normal 35 41 35 41 I-upper_bound

< 0 1 42 43 O
3 2 3 44 45 B-upper_bound
X 4 5 46 47 I-upper_bound
institutional 6 19 48 61 I-upper_bound
upper 20 25 62 67 I-upper_bound
limit 26 31 68 73 I-upper_bound
of 32 34 74 76 I-upper_bound
normal 35 41 77 83 I-upper_bound
ALT(SGPT 42 50 84 92 B-clinical_variable
) 50 51 92 93 O

Acceptable 0 10 94 104 O
contraindications 11 28 105 122 O
to 29 31 123 125 O
surgery 32 39 126 133 B-allergy_name

Adequate 0 8 134 142 O
renal 9 14 143 148 B-chronic_disease
function 15 23 149 157 I-chronic_disease

Age 0 3 158 161 B-age
of 4 6 162 164 O
greater 7 14 165 172 O
than 15 19 173 177 O
or 20 22 178 180 O
equal 23 28 181 186 O
to 29 31 187 189 O
18 32 34 190 192 B-lower_bound
years 35 40 193 198 I-lower_bound

Agreement 0 9 199 208 O
not 10 13 209 212 O
to 14 16 213 215 O
donate 17 23 216 222 O
blood 24 29 223 228 O
or 30 32 229 231 O
blood 33 38 232 237 O
products 39 47 238 246 O
during 48 54 247 253 O
the 55 58 254 257 O
study 59 64 258 263 O
and 65 68 264 267 O
for 69 72 268 271 O
7 73 74 272 273 O
months 75 81 274 280 O
after 82 87 281 286 O
discontinuation 88 103 287 302 O
of 104 106 303 305 O
vismodegib 107 117 306 316 B-treatment

All 0 3 317 320 O
lesions 4 11 321 328 O
that 12 16 329 333 O
the 17 20 334 337 O
investigator 21 33 338 350 O
proposes 34 42 351 359 O
to 43 45 360 362 O
follow 46 52 363 369 O
as 53 55 370 372 O
target 56 62 373 379 O
lesions 63 70 380 387 O
during 71 77 388 394 O
the 78 81 395 398 O
course 82 88 399 405 O
of 89 91 406 408 O
the 92 95 409 412 O
study 96 101 413 418 O
must 102 106 419 423 O
have 107 111 424 428 O
previously 112 122 429 439 O
been 123 127 440 444 O
histologically 128 142 445 459 O
confirmed 143 152 460 469 O
as 153 155 470 472 O
BCC 156 159 473 476 B-cancer

Anticipated 0 11 477 488 O
substantial 12 23 489 500 O
morbidity 24 33 501 510 O
and/or 34 40 511 517 O
major 41 46 518 523 O
deformity 47 56 524 533 O
from 57 61 534 538 O
surgery 62 69 539 546 B-treatment
( 70 71 547 548 O
e.g. 71 75 548 552 O
removal 76 83 553 560 O
of 84 86 561 563 O
a 87 88 564 565 O
major 89 94 566 571 O
facial 95 101 572 578 O
structure 102 111 579 588 O
, 111 112 588 589 O
such 113 117 590 594 O
as 118 120 595 597 O
nose 121 125 598 602 O
, 125 126 602 603 O
ear 127 130 604 607 O
, 130 131 607 608 O
eyelid 132 138 609 615 O
, 138 139 615 616 O
eye 140 143 617 620 O
, 143 144 620 621 O
or 145 147 622 624 O
jaw 148 151 625 628 O
; 151 152 628 629 O
or 153 155 630 632 O
requirement 156 167 633 644 O
for 168 171 645 648 O
upper 172 177 649 654 B-treatment
limb 178 182 655 659 I-treatment
amputation 183 193 660 670 I-treatment
) 193 194 670 671 O

BCC 0 3 672 675 B-cancer
that 4 8 676 680 O
has 9 12 681 684 O
recurred 13 21 685 693 O
in 22 24 694 696 O
the 25 28 697 700 O
same 29 33 701 705 O
location 34 42 706 714 O
after 43 48 715 720 O
two 49 52 721 724 B-lower_bound
or 53 55 725 727 O
more 56 60 728 732 O
surgical 61 69 733 741 B-treatment
procedures 70 80 742 752 I-treatment
and 81 84 753 756 O
successful 85 95 757 767 O
curative 96 104 768 776 B-treatment
resection 105 114 777 786 I-treatment
is 115 117 787 789 O
deemed 118 124 790 796 O
unlikely 125 133 797 805 O

Complete 0 8 806 814 O
surgical 9 17 815 823 B-treatment
resection 18 27 824 833 I-treatment
is 28 30 834 836 O
not 31 34 837 840 O
possible 35 43 841 849 O
or 44 46 850 852 O
is 47 49 853 855 O
deemed 50 56 856 862 O
excessively 57 68 863 874 O
morbid 69 75 875 881 O
( 76 77 882 883 O
e.g. 77 81 883 887 O
invasion 82 90 888 896 O
into 91 95 897 901 O
cranial 96 103 902 909 O
nerves 104 110 910 916 O
or 111 113 917 919 O
skull 114 119 920 925 O
base 120 124 926 930 O
, 124 125 930 931 O
proximity 126 135 932 941 O
to 136 138 942 944 O
brain 139 144 945 950 O
, 144 145 950 951 O
spinal 146 152 952 958 O
canal 153 158 959 964 O
, 158 159 964 965 O
or 160 162 966 968 O
orbit 163 168 969 974 O
) 168 169 974 975 O

Concurrent 0 10 976 986 O
non 11 14 987 990 O
- 14 15 990 991 O
protocol 15 23 991 999 O
- 23 24 999 1000 O
specified 24 33 1000 1009 O
anti 34 38 1010 1014 B-treatment
- 38 39 1014 1015 I-treatment
tumor 39 44 1015 1020 I-treatment
therapy 45 52 1021 1028 I-treatment
( 53 54 1029 1030 O
e.g. 54 58 1030 1034 O
, 58 59 1034 1035 O
chemotherapy 60 72 1036 1048 B-treatment
, 72 73 1048 1049 O
other 74 79 1050 1055 O
targeted 80 88 1056 1064 B-treatment
therapy 89 96 1065 1072 I-treatment
, 96 97 1072 1073 O
topical 98 105 1074 1081 B-treatment
therapy 106 113 1082 1089 I-treatment
such 114 118 1090 1094 O
as 119 121 1095 1097 O
5 122 123 1098 1099 B-treatment
- 123 124 1099 1100 I-treatment
Fluorouracil 124 136 1100 1112 I-treatment
or 137 139 1113 1115 O
imiquimod 140 149 1116 1125 B-treatment
, 149 150 1125 1126 O
radiation 151 160 1127 1136 B-treatment
therapy 161 168 1137 1144 I-treatment
, 168 169 1144 1145 O
surgery 170 177 1146 1153 B-treatment
, 177 178 1153 1154 O
or 179 181 1155 1157 O
photodynamic 182 194 1158 1170 B-treatment
therapy 195 202 1171 1178 I-treatment

For 0 3 1179 1182 O
patients 4 12 1183 1191 O
with 13 17 1192 1196 O
multiple 18 26 1197 1205 B-cancer
cutaneous 27 36 1206 1215 I-cancer
BCCs 37 41 1216 1220 I-cancer
at 42 44 1221 1223 O
baseline 45 53 1224 1232 O
that 54 58 1233 1237 O
are 59 62 1238 1241 O
not 63 66 1242 1245 O
designated 67 77 1246 1256 O
by 78 80 1257 1259 O
the 81 84 1260 1263 O
investigator 85 97 1264 1276 O
as 98 100 1277 1279 O
target 101 107 1280 1286 O
lesions 108 115 1287 1294 O
, 115 116 1294 1295 O
treatment 117 126 1296 1305 B-treatment
of 127 129 1306 1308 O
these 130 135 1309 1314 O
non 136 139 1315 1318 O
- 139 140 1318 1319 O
target 140 146 1319 1325 O
BCCs 147 151 1326 1330 O
with 152 156 1331 1335 O
surgery 157 164 1336 1343 B-treatment
may 165 168 1344 1347 O
be 169 171 1348 1350 O
permitted 172 181 1351 1360 O
but 182 185 1361 1364 O
must 186 190 1365 1369 O
be 191 193 1370 1372 O
discussed 194 203 1373 1382 O
with 204 208 1383 1387 O
Data 209 213 1388 1392 O
Coordinator 214 225 1393 1404 O
prior 226 231 1405 1410 B-treatment
to 232 234 1411 1413 I-treatment
any 235 238 1414 1417 I-treatment
surgical 239 247 1418 1426 I-treatment
procedure 248 257 1427 1436 I-treatment

HIV 0 3 1437 1440 B-chronic_disease
- 3 4 1440 1441 O
positive 4 12 1441 1449 O
patients 13 21 1450 1458 O
on 22 24 1459 1461 O
combination 25 36 1462 1473 O
antiretroviral 37 51 1474 1488 B-treatment
therapy 52 59 1489 1496 I-treatment
, 59 60 1496 1497 O
because 61 68 1498 1505 O
of 69 71 1506 1508 O
the 72 75 1509 1512 O
potential 76 85 1513 1522 O
for 86 89 1523 1526 O
pharmacokinetic 90 105 1527 1542 O
interactions 106 118 1543 1555 O
with 119 123 1556 1560 O
vismodegib 124 134 1561 1571 B-treatment

History 0 7 1572 1579 O
of 8 10 1580 1582 O
other 11 16 1583 1588 O
disease 17 24 1589 1596 O
, 24 25 1596 1597 O
metabolic 26 35 1598 1607 B-chronic_disease
dysfunction 36 47 1608 1619 I-chronic_disease
, 47 48 1619 1620 O
physical 49 57 1621 1629 O
examination 58 69 1630 1641 O
finding 70 77 1642 1649 O
, 77 78 1649 1650 O
or 79 81 1651 1653 O
clinical 82 90 1654 1662 O
laboratory 91 101 1663 1673 O
finding 102 109 1674 1681 O
giving 110 116 1682 1688 O
reasonable 117 127 1689 1699 O
suspicion 128 137 1700 1709 O
of 138 140 1710 1712 O
a 141 142 1713 1714 O
disease 143 150 1715 1722 O
or 151 153 1723 1725 O
condition 154 163 1726 1735 O
that 164 168 1736 1740 O
contraindicates 169 184 1741 1756 O
use 185 188 1757 1760 O
of 189 191 1761 1763 O
an 192 194 1764 1766 O
investigational 195 210 1767 1782 B-treatment
drug 211 215 1783 1787 I-treatment
or 216 218 1788 1790 O
that 219 223 1791 1795 O
might 224 229 1796 1801 O
affect 230 236 1802 1808 O
interpretation 237 251 1809 1823 O
of 252 254 1824 1826 O
the 255 258 1827 1830 O
results 259 266 1831 1838 O
of 267 269 1839 1841 O
the 270 273 1842 1845 O
study 274 279 1846 1851 O
or 280 282 1852 1854 O
renders 283 290 1855 1862 O
the 291 294 1863 1866 O
patient 295 302 1867 1874 O
at 303 305 1875 1877 O
high 306 310 1878 1882 O
risk 311 315 1883 1887 O
form 316 320 1888 1892 O
treatment 321 330 1893 1902 B-treatment
complications 331 344 1903 1916 O

Life 0 4 1917 1921 B-clinical_variable
expectancy 5 15 1922 1932 I-clinical_variable
of 16 18 1933 1935 O
< 19 20 1936 1937 O
1 20 21 1937 1938 B-upper_bound
year 22 26 1939 1943 I-upper_bound

Locally 0 7 1944 1951 B-cancer
advanced 8 16 1952 1960 I-cancer
disease 17 24 1961 1968 I-cancer
is 25 27 1969 1971 O
considered 28 38 1972 1982 O
to 39 41 1983 1985 O
include 42 49 1986 1993 O
involved 50 58 1994 2002 O
lymph 59 64 2003 2008 O
nodes 65 70 2009 2014 O
of 71 73 2015 2017 O
the 74 77 2018 2021 O
neck 78 82 2022 2026 O

Male 0 4 2027 2031 B-gender
patients 5 13 2032 2040 I-gender
must 14 18 2041 2045 O
use 19 22 2046 2049 B-contraception_consent
condoms 23 30 2050 2057 I-contraception_consent
at 31 33 2058 2060 I-contraception_consent
all 34 37 2061 2064 I-contraception_consent
times 38 43 2065 2070 I-contraception_consent
, 43 44 2070 2071 O
even 45 49 2072 2076 O
after 50 55 2077 2082 O
a 56 57 2083 2084 O
vasectomy 58 67 2085 2094 B-treatment
, 67 68 2094 2095 O
during 69 75 2096 2102 O
sexual 76 82 2103 2109 O
intercourse 83 94 2110 2121 O
with 95 99 2122 2126 O
female 100 106 2127 2133 B-gender
partners 107 115 2134 2142 I-gender
of 116 118 2143 2145 O
reproductive 119 131 2146 2158 O
potential 132 141 2159 2168 O
during 142 148 2169 2175 O
treatment 149 158 2176 2185 B-treatment
with 159 163 2186 2190 I-treatment
vismodegib 164 174 2191 2201 I-treatment
and 175 178 2202 2205 O
for 179 182 2206 2209 O
2 183 184 2210 2211 B-upper_bound
months 185 191 2212 2218 I-upper_bound
after 192 197 2219 2224 I-upper_bound
the 198 201 2225 2228 O
last 202 206 2229 2233 O
dose 207 211 2234 2238 O
to 212 214 2239 2241 O
avoid 215 220 2242 2247 O
exposing 221 229 2248 2256 O
a 230 231 2257 2258 O
pregnant 232 240 2259 2267 B-pregnancy
partner 241 248 2268 2275 O
and 249 252 2276 2279 O
unborn 253 259 2280 2286 O
fetus 260 265 2287 2292 O
to 266 268 2293 2295 O
vismodegib 269 279 2296 2306 O

Male 0 4 2307 2311 B-gender
patients 5 13 2312 2320 I-gender
must 14 18 2321 2325 O
use 19 22 2326 2329 B-contraception_consent
condoms 23 30 2330 2337 I-contraception_consent
at 31 33 2338 2340 I-contraception_consent
all 34 37 2341 2344 I-contraception_consent
times 38 43 2345 2350 I-contraception_consent
, 43 44 2350 2351 O
even 45 49 2352 2356 O
after 50 55 2357 2362 O
a 56 57 2363 2364 O
vasectomy 58 67 2365 2374 B-treatment
, 67 68 2374 2375 O
during 69 75 2376 2382 O
sexual 76 82 2383 2389 O
intercourse 83 94 2390 2401 O
with 95 99 2402 2406 O
pregnant 100 108 2407 2415 B-pregnancy
partners 109 117 2416 2424 O
or 118 120 2425 2427 O
female 121 127 2428 2434 B-gender
partners 128 136 2435 2443 I-gender
of 137 139 2444 2446 O
reproductive 140 152 2447 2459 O
potential 153 162 2460 2469 O
during 163 169 2470 2476 O
treatment 170 179 2477 2486 B-treatment
with 180 184 2487 2491 O
vismodegib 185 195 2492 2502 B-treatment

Medical 0 7 2503 2510 O
contraindication 8 24 2511 2527 O
to 25 27 2528 2530 O
surgery 28 35 2531 2538 B-treatment

Patient 0 7 2539 2546 O
refusal 8 15 2547 2554 O
of 16 18 2555 2557 O
surgery 19 26 2558 2565 B-treatment
due 27 30 2566 2569 O
to 31 33 2570 2572 O
anticipated 34 45 2573 2584 B-chronic_disease
morbidity 46 55 2585 2594 I-chronic_disease

Patients 0 8 2595 2603 O
who 9 12 2604 2607 O
are 13 16 2608 2611 O
unable 17 23 2612 2618 O
or 24 26 2619 2621 O
are 27 30 2622 2625 O
unwilling 31 40 2626 2635 B-contraception_consent
to 41 43 2636 2638 I-contraception_consent
adhere 44 50 2639 2645 I-contraception_consent
to 51 53 2646 2648 I-contraception_consent
the 54 57 2649 2652 I-contraception_consent
required 58 66 2653 2661 I-contraception_consent
contraceptive 67 80 2662 2675 I-contraception_consent
methods 81 88 2676 2683 I-contraception_consent
are 89 92 2684 2687 O
excluded 93 101 2688 2696 O
from 102 106 2697 2701 O
the 107 110 2702 2705 O
study 111 116 2706 2711 O

Patients 0 8 2712 2720 O
with 9 13 2721 2725 O
any 14 17 2726 2729 O
condition 18 27 2730 2739 O
that 28 32 2740 2744 O
may 33 36 2745 2748 O
impair 37 43 2749 2755 O
the 44 47 2756 2759 O
ability 48 55 2760 2767 O
to 56 58 2768 2770 O
swallow 59 66 2771 2778 O
or 67 69 2779 2781 O
absorb 70 76 2782 2788 O
oral 77 81 2789 2793 B-treatment
medications 82 93 2794 2805 I-treatment
/ 93 94 2805 2806 O
investigational 94 109 2806 2821 O
product 110 117 2822 2829 O

Patients 0 8 2830 2838 O
with 9 13 2839 2843 O
distant 14 21 2844 2851 B-cancer
metastasis 22 32 2852 2862 I-cancer
( 33 34 2863 2864 O
e.g. 34 38 2864 2868 O
spread 39 45 2869 2875 O
to 46 48 2876 2878 O
distant 49 56 2879 2886 O
areas 57 62 2887 2892 O
outside 63 70 2893 2900 O
the 71 74 2901 2904 O
regional 75 83 2905 2913 O
lymph 84 89 2914 2919 O
nodes 90 95 2920 2925 O
, 95 96 2925 2926 O
clearly 97 104 2927 2934 O
non 105 108 2935 2938 O
contiguous 109 119 2939 2949 O
areas 120 125 2950 2955 O
of 126 128 2956 2958 O
bone 129 133 2959 2963 O
involvement 134 145 2964 2975 O
, 145 146 2975 2976 O
or 147 149 2977 2979 O
distant 150 157 2980 2987 O
metastasis 158 168 2988 2998 O
to 169 171 2999 3001 O
lung 172 176 3002 3006 O
, 176 177 3006 3007 O
brain 178 183 3008 3013 O
, 183 184 3013 3014 O
liver 185 190 3015 3020 O
or 191 193 3021 3023 O
other 194 199 3024 3029 O
visceral 200 208 3030 3038 O
organs 209 215 3039 3045 O
) 215 216 3045 3046 O

Patients 0 8 3047 3055 O
with 9 13 3056 3060 O
locally 14 21 3061 3068 O
advanced 22 30 3069 3077 O
BCC 31 34 3078 3081 B-cancer
of 35 37 3082 3084 O
the 38 41 3085 3088 O
head 42 46 3089 3093 O
and 47 50 3094 3097 O
neck 51 55 3098 3102 O
, 55 56 3102 3103 O
consisting 57 67 3104 3114 O
of 68 70 3115 3117 O
at 71 73 3118 3120 O
least 74 79 3121 3126 O
one 80 83 3127 3130 B-lower_bound
histologically 84 98 3131 3145 O
or 99 101 3146 3148 O
cytologically 102 115 3149 3162 O
confirmed 116 125 3163 3172 O
lesion 126 132 3173 3179 B-clinical_variable
greater 133 140 3180 3187 O
than 141 145 3188 3192 O
or 146 148 3193 3195 O
equal 149 154 3196 3201 O
to 155 157 3202 3204 O
20 158 160 3205 3207 B-lower_bound
mm 161 163 3208 3210 I-lower_bound
in 164 166 3211 3213 O
longest 167 174 3214 3221 O
diameter 175 183 3222 3230 O
that 184 188 3231 3235 O
is 189 191 3236 3238 O
considered 192 202 3239 3249 O
to 203 205 3250 3252 O
be 206 208 3253 3255 O
inoperable 209 219 3256 3266 O
or 220 222 3267 3269 O
to 223 225 3270 3272 O
have 226 230 3273 3277 O
a 231 232 3278 3279 O
medical 233 240 3280 3287 O
contraindication 241 257 3288 3304 O
to 258 260 3305 3307 O
surgery 261 268 3308 3315 B-treatment
, 268 269 3315 3316 O
in 270 272 3317 3319 O
the 273 276 3320 3323 O
opinion 277 284 3324 3331 O
of 285 287 3332 3334 O
a 288 289 3335 3336 O
Mohs 290 294 3337 3341 O
dermatologic 295 307 3342 3354 O
surgeon 308 315 3355 3362 O
, 315 316 3362 3363 O
head 317 321 3364 3368 O
and 322 325 3369 3372 O
neck 326 330 3373 3377 O
surgeon 331 338 3378 3385 O
, 338 339 3385 3386 O
or 340 342 3387 3389 O
plastic 343 350 3390 3397 O
surgeon 351 358 3398 3405 O

Patients 0 8 3406 3414 O
with 9 13 3415 3419 O
nevoid 14 20 3420 3426 B-cancer
BCC 21 24 3427 3430 I-cancer
syndrome 25 33 3431 3439 I-cancer
( 34 35 3440 3441 I-cancer
Gorlin 35 41 3441 3447 I-cancer
syndrome 42 50 3448 3456 I-cancer
) 50 51 3456 3457 I-cancer
should 52 58 3458 3464 O
not 59 62 3465 3468 O
enroll 63 69 3469 3475 O
in 70 72 3476 3478 O
this 73 77 3479 3483 O
study 78 83 3484 3489 O

Patients 0 8 3490 3498 O
with 9 13 3499 3503 O
widespread 14 24 3504 3514 B-cancer
superficial 25 36 3515 3526 I-cancer
multifocal 37 47 3527 3537 I-cancer
BCC 48 51 3538 3541 I-cancer
who 52 55 3542 3545 O
are 56 59 3546 3549 O
considered 60 70 3550 3560 O
unresectable 71 83 3561 3573 O
due 84 87 3574 3577 O
to 88 90 3578 3580 O
breadth 91 98 3581 3588 O
of 99 101 3589 3591 O
involvement 102 113 3592 3603 O
and 114 117 3604 3607 O
do 118 120 3608 3610 O
not 121 124 3611 3614 O
have 125 129 3615 3619 O
a 130 131 3620 3621 O
single 132 138 3622 3628 O
definable 139 148 3629 3638 O
area 149 153 3639 3643 O
of 154 156 3644 3646 O
disease 157 164 3647 3654 O
amenable 165 173 3655 3663 O
to 174 176 3664 3666 O
radiation 177 186 3667 3676 B-treatment
therapy 187 194 3677 3684 I-treatment
targeting 195 204 3685 3694 O

Pregnant 0 8 3695 3703 B-pregnancy

Prior 0 5 3704 3709 B-treatment
radiation 6 15 3710 3719 I-treatment
therapy 16 23 3720 3727 I-treatment
is 24 26 3728 3730 O
acceptable 27 37 3731 3741 O
but 38 41 3742 3745 O
there 42 47 3746 3751 O
can 48 51 3752 3755 O
not 51 54 3755 3758 O
be 55 57 3759 3761 O
major 58 63 3762 3767 O
overlap 64 71 3768 3775 O
of 72 74 3776 3778 O
the 75 78 3779 3782 O
previously 79 89 3783 3793 O
irradiated 90 100 3794 3804 O
tissues 101 108 3805 3812 O
with 109 113 3813 3817 O
the 114 117 3818 3821 O
new 118 121 3822 3825 O
radiation 122 131 3826 3835 B-treatment
treatment 132 141 3836 3845 I-treatment
volumes 142 149 3846 3853 O
anticipated 150 161 3854 3865 O
to 162 164 3866 3868 O
be 165 167 3869 3871 O
delivered 168 177 3872 3881 O
for 178 181 3882 3885 O
the 182 185 3886 3889 O
purposes 186 194 3890 3898 O
of 195 197 3899 3901 O
this 198 202 3902 3906 O
protocol 203 211 3907 3915 O
, 211 212 3915 3916 O
in 213 215 3917 3919 O
such 216 220 3920 3924 O
a 221 222 3925 3926 O
way 223 226 3927 3930 O
that 227 231 3931 3935 O
curative 232 240 3936 3944 O
intent 241 247 3945 3951 O
with 248 252 3952 3956 O
radiation 253 262 3957 3966 O
can 263 266 3967 3970 O
not 266 269 3970 3973 O
be 270 272 3974 3976 O
met 273 276 3977 3980 O

Prior 0 5 3981 3986 O
radiotherapy 6 18 3987 3999 B-treatment
to 19 21 4000 4002 O
the 22 25 4003 4006 O
region 26 32 4007 4013 O
of 33 35 4014 4016 O
the 36 39 4017 4020 O
study 40 45 4021 4026 O
cancer 46 52 4027 4033 B-cancer
that 53 57 4034 4038 O
would 58 63 4039 4044 O
result 64 70 4045 4051 O
in 71 73 4052 4054 O
overlap 74 81 4055 4062 O
of 82 84 4063 4065 O
radiation 85 94 4066 4075 B-treatment
therapy 95 102 4076 4083 I-treatment
fields 103 109 4084 4090 O
in 110 112 4091 4093 O
such 113 117 4094 4098 O
a 118 119 4099 4100 O
way 120 123 4101 4104 O
that 124 128 4105 4109 O
curative 129 137 4110 4118 O
intent 138 144 4119 4125 O
with 145 149 4126 4130 O
radiation 150 159 4131 4140 O
can 160 163 4141 4144 O
not 163 166 4144 4147 O
be 167 169 4148 4150 O
met 170 173 4151 4154 O

Prior 0 5 4155 4160 B-treatment
vismodegib 6 16 4161 4171 I-treatment
or 17 19 4172 4174 O
other 20 25 4175 4180 O
antagonists 26 37 4181 4192 O
of 38 40 4193 4195 O
the 41 44 4196 4199 O
Hh 45 47 4200 4202 O
pathway 48 55 4203 4210 O

Recent 0 6 4211 4217 O
( 7 8 4218 4219 O
within 8 14 4219 4225 O
4 15 16 4226 4227 B-upper_bound
weeks 17 22 4228 4233 I-upper_bound
of 23 25 4234 4236 O
Registration 26 38 4237 4249 O
) 38 39 4249 4250 O
, 39 40 4250 4251 O
current 41 48 4252 4259 O
, 48 49 4259 4260 O
or 50 52 4261 4263 O
planned 53 60 4264 4271 O
participation 61 74 4272 4285 O
in 75 77 4286 4288 O
another 78 85 4289 4296 O
experimental 86 98 4297 4309 B-treatment
drug 99 103 4310 4314 I-treatment
study 104 109 4315 4320 I-treatment

The 0 3 4321 4324 O
patient 4 11 4325 4332 O
should 12 18 4333 4339 O
be 19 21 4340 4342 O
considered 22 32 4343 4353 O
a 33 34 4354 4355 O
candidate 35 44 4356 4365 O
for 45 48 4366 4369 O
radiotherapy 49 61 4370 4382 B-treatment
and 62 65 4383 4386 O
should 66 72 4387 4393 O
not 73 76 4394 4397 O
have 77 81 4398 4402 O
medical 82 89 4403 4410 O
contraindications 90 107 4411 4428 O
to 108 110 4429 4431 O
receipt 111 118 4432 4439 O
of 119 121 4440 4442 O
radiation 122 131 4443 4452 B-treatment
therapy 132 139 4453 4460 I-treatment

Uncontrolled 0 12 4461 4473 O
intercurrent 13 25 4474 4486 O
illness 26 33 4487 4494 O
including 34 43 4495 4504 O
, 43 44 4504 4505 O
but 45 48 4506 4509 O
not 49 52 4510 4513 O
limited 53 60 4514 4521 O
to 61 63 4522 4524 O
, 63 64 4524 4525 O
ongoing 65 72 4526 4533 O
or 73 75 4534 4536 O
active 76 82 4537 4543 B-chronic_disease
infection 83 92 4544 4553 I-chronic_disease
or 93 95 4554 4556 O
psychiatric 96 107 4557 4568 B-chronic_disease
illness 108 115 4569 4576 I-chronic_disease
/ 115 116 4576 4577 I-chronic_disease
social 116 122 4577 4583 I-chronic_disease
situations 123 133 4584 4594 I-chronic_disease
that 134 138 4595 4599 O
would 139 144 4600 4605 O
limit 145 150 4606 4611 O
compliance 151 161 4612 4622 O
with 162 166 4623 4627 O
study 167 172 4628 4633 O
requirements 173 185 4634 4646 O

Verify 0 6 4647 4653 O
the 7 10 4654 4657 O
pregnancy 11 20 4658 4667 B-pregnancy
status 21 27 4668 4674 O
of 28 30 4675 4677 O
females 31 38 4678 4685 B-gender
of 39 41 4686 4688 O
reproductive 42 54 4689 4701 O
potential 55 64 4702 4711 O
within 65 71 4712 4718 O
7 72 73 4719 4720 B-upper_bound
days 74 78 4721 4725 I-upper_bound
prior 79 84 4726 4731 I-upper_bound
to 85 87 4732 4734 O
initiating 88 98 4735 4745 O
vismodegib 99 109 4746 4756 B-treatment

Women 0 5 4757 4762 B-gender
of 6 8 4763 4765 O
reproductive 9 21 4766 4778 O
potential 22 31 4779 4788 O
are 32 35 4789 4792 O
required 36 44 4793 4801 O
to 45 47 4802 4804 O
use 48 51 4805 4808 B-contraception_consent
two 52 55 4809 4812 I-contraception_consent
forms 56 61 4813 4818 I-contraception_consent
of 62 64 4819 4821 I-contraception_consent
acceptable 65 75 4822 4832 I-contraception_consent
contraception 76 89 4833 4846 I-contraception_consent
( 90 91 4847 4848 O
including 91 100 4848 4857 O
one 101 104 4858 4861 O
acceptable 105 115 4862 4872 O
barrier 116 123 4873 4880 B-contraception_consent
method 124 130 4881 4887 I-contraception_consent
with 131 135 4888 4892 I-contraception_consent
spermicide 136 146 4893 4903 I-contraception_consent
) 146 147 4903 4904 O
during 148 154 4905 4911 O
therapy 155 162 4912 4919 B-treatment
and 163 166 4920 4923 O
for 167 170 4924 4927 O
7 171 172 4928 4929 B-upper_bound
months 173 179 4930 4936 I-upper_bound
after 180 185 4937 4942 I-upper_bound
completing 186 196 4943 4953 O
therapy 197 204 4954 4961 O

Zubrod 0 6 4962 4968 B-clinical_variable
Performance 7 18 4969 4980 I-clinical_variable
Status 19 25 4981 4987 I-clinical_variable
0 26 27 4988 4989 B-lower_bound
- 27 28 4989 4990 O
2 28 29 4990 4991 B-upper_bound

active 0 6 4992 4998 B-chronic_disease
peptic 7 13 4999 5005 I-chronic_disease
ulcer 14 19 5006 5011 I-chronic_disease
disease 20 27 5012 5019 I-chronic_disease

agreement 0 9 5020 5029 O
not 10 13 5030 5033 O
to 14 16 5034 5036 O
donate 17 23 5037 5043 O
sperm 24 29 5044 5049 O
during 30 36 5050 5056 O
the 37 40 5057 5060 O
study 41 46 5061 5066 O
and 47 50 5067 5070 O
for 51 54 5071 5074 O
3 55 56 5075 5076 B-upper_bound
months 57 63 5077 5083 I-upper_bound
after 64 69 5084 5089 I-upper_bound
the 70 73 5090 5093 O
final 74 79 5094 5099 O
dose 80 84 5100 5104 O
of 85 87 5105 5107 O
vismodegib 88 98 5108 5118 B-treatment

agreement 0 9 5119 5128 O
not 10 13 5129 5132 O
to 14 16 5133 5135 O
donate 17 23 5136 5142 O
sperm 24 29 5143 5148 O
during 30 36 5149 5155 O
the 37 40 5156 5159 O
study 41 46 5160 5165 O
and 47 50 5166 5169 O
for 51 54 5170 5173 O
7 55 56 5174 5175 B-upper_bound
months 57 63 5176 5182 I-upper_bound
after 64 69 5183 5188 O
discontinuation 70 85 5189 5204 O
of 86 88 5205 5207 O
vismodegib 89 99 5208 5218 B-treatment

any 0 3 5219 5222 O
lesion 4 10 5223 5229 O
, 10 11 5229 5230 O
whether 12 19 5231 5238 O
induced 20 27 5239 5246 O
by 28 30 5247 5249 O
tumor 31 36 5250 5255 B-cancer
, 36 37 5255 5256 O
radiation 38 47 5257 5266 B-treatment
or 48 50 5267 5269 O
other 51 56 5270 5275 O
conditions 57 67 5276 5286 O
, 67 68 5286 5287 O
which 69 74 5288 5293 O
makes 75 80 5294 5299 O
it 81 83 5300 5302 O
difficult 84 93 5303 5312 O
to 94 96 5313 5315 O
swallow 97 104 5316 5323 O
capsules 105 113 5324 5332 O
or 114 116 5333 5335 O
pills 117 122 5336 5341 O

greater 0 7 5342 5349 O
than 8 12 5350 5354 O
or 13 15 5355 5357 O
equal 16 21 5358 5363 O
to 22 24 5364 5366 O
1000 25 29 5367 5371 B-lower_bound
cells 30 35 5372 5377 I-lower_bound
/ 35 36 5377 5378 I-lower_bound
mm3 36 39 5378 5381 I-lower_bound
platelets 40 49 5382 5391 B-clinical_variable

greater 0 7 5392 5399 O
than 8 12 5400 5404 O
or 13 15 5405 5407 O
equal 16 21 5408 5413 O
to 22 24 5414 5416 O
75,000 25 31 5417 5423 B-lower_bound
cells 32 37 5424 5429 I-lower_bound
/ 37 38 5429 5430 I-lower_bound
mm3 38 41 5430 5433 I-lower_bound
hemoglobin 42 52 5434 5444 B-clinical_variable

greater 0 7 5445 5452 O
than 8 12 5453 5457 O
or 13 15 5458 5460 O
equal 16 21 5461 5466 O
to 22 24 5467 5469 O
8.5 25 28 5470 5473 B-lower_bound
g 29 30 5474 5475 I-lower_bound
/ 30 31 5475 5476 I-lower_bound
dl 31 33 5476 5478 I-lower_bound
( 34 35 5479 5480 O
recommended 35 46 5480 5491 O
cutoff 47 53 5492 5498 O
subject 54 61 5499 5506 O
to 62 64 5507 5509 O
judgment 65 73 5510 5518 O
of 74 76 5519 5521 O
medical 77 84 5522 5529 O
oncologist 85 95 5530 5540 O
) 95 96 5540 5541 O
, 96 97 5541 5542 O
but 98 101 5543 5546 O
can 102 105 5547 5550 O
not 105 108 5550 5553 O
be 109 111 5554 5556 O
transfusion 112 123 5557 5568 O
dependent 124 133 5569 5578 O

lactating 0 9 5579 5588 O
women 10 15 5589 5594 B-gender

leukocytes 0 10 5595 5605 B-clinical_variable
: 10 11 5605 5606 O
> 12 13 5607 5608 O
3,000 14 19 5609 5614 B-lower_bound
/ 19 20 5614 5615 I-lower_bound
mcL 20 23 5615 5618 I-lower_bound
absolute 24 32 5619 5627 B-clinical_variable
neutrophil 33 43 5628 5638 I-clinical_variable
count 44 49 5639 5644 I-clinical_variable

malabsorption 0 13 5645 5658 B-chronic_disease
syndrome 14 22 5659 5667 I-chronic_disease

male 0 4 5668 5672 B-gender
patients 5 13 5673 5681 I-gender

prior 0 5 5682 5687 B-treatment
surgical 6 14 5688 5696 I-treatment
procedures 15 25 5697 5707 I-treatment
affecting 26 35 5708 5717 O
absorption 36 46 5718 5728 O
including 47 56 5729 5738 O
, 56 57 5738 5739 O
but 58 61 5740 5743 O
not 62 65 5744 5747 O
limited 66 73 5748 5755 O
to 74 76 5756 5758 O
major 77 82 5759 5764 B-treatment
resection 83 92 5765 5774 I-treatment
of 93 95 5775 5777 I-treatment
stomach 96 103 5778 5785 I-treatment
or 104 106 5786 5788 O
small 107 112 5789 5794 B-treatment
bowel 113 118 5795 5800 I-treatment

total 0 5 5801 5806 O
bilirubin 6 15 5807 5816 B-clinical_variable
: 15 16 5816 5817 O
less 17 21 5818 5822 O
than 22 26 5823 5827 O
or 27 29 5828 5830 O
equal 30 35 5831 5836 O
to 36 38 5837 5839 O
1.5x 39 43 5840 5844 B-upper_bound
institutional 44 57 5845 5858 I-upper_bound
ULN 58 61 5859 5862 I-upper_bound
or 62 64 5863 5865 O
within 65 71 5866 5872 O
3x 72 74 5873 5875 B-upper_bound
the 75 78 5876 5879 I-upper_bound
ULN 79 82 5880 5883 I-upper_bound
for 83 86 5884 5887 O
patients 87 95 5888 5896 O
with 96 100 5897 5901 O
Gilbert 101 108 5902 5909 B-chronic_disease
disease 109 116 5910 5917 I-chronic_disease
AST(SGOT 117 125 5918 5926 B-clinical_variable
) 125 126 5926 5927 I-clinical_variable

within 0 6 5928 5934 O
normal 7 13 5935 5941 O
institutional 14 27 5942 5955 O
limits 28 34 5956 5962 O
OR 35 37 5963 5965 O
creatinine 38 48 5966 5976 B-clinical_variable
clearance 49 58 5977 5986 I-clinical_variable
: 58 59 5986 5987 O
> 60 61 5988 5989 O
60 62 64 5990 5992 B-lower_bound
mL 65 67 5993 5995 I-lower_bound
/ 67 68 5995 5996 I-lower_bound
min/1.73 68 76 5996 6004 I-lower_bound
m2 77 79 6005 6007 I-lower_bound
for 80 83 6008 6011 O
patients 84 92 6012 6020 O
with 93 97 6021 6025 O
creatinine 98 108 6026 6036 B-clinical_variable
levels 109 115 6037 6043 I-clinical_variable
above 116 121 6044 6049 O
institutional 122 135 6050 6063 O
normal 136 142 6064 6070 O

women 0 5 6071 6076 B-gender
of 6 8 6077 6079 O
childbearing 9 21 6080 6092 O
potential 22 31 6093 6102 O
, 31 32 6102 6103 O
a 33 34 6104 6105 O
negative 35 43 6106 6114 B-pregnancy
pregnancy 44 53 6115 6124 I-pregnancy
test 54 58 6125 6129 O
within 59 65 6130 6136 O
7 66 67 6137 6138 B-upper_bound
days 68 72 6139 6143 I-upper_bound
prior 73 78 6144 6149 I-upper_bound
to 79 81 6150 6152 O
commencement 82 94 6153 6165 O
of 95 97 6166 6168 O
dosing 98 104 6169 6175 O
is 105 107 6176 6178 O
required 108 116 6179 6187 O

